A similar diverging pattern was observed in relation to MSI and p53 status: TROP2 expression demonstrated prognostic significance solely in MSS CRC and those with abnormal p53 expression, with no survival distinctions noted in MSI‐high or p53 wild‐type neoplasms. The gene discussed is TACSTD2; the disease is neoplasm.